NeuroEM Therapeutics
Tampa, US · Delaware corporation
Healthtech
Founders & leadership
CP
Chuck PapageorgiouChief Executive Officer
ML
Mitch LarimoreDirector
JG
Jonathan GordonDirector
Reported raises · per SEC filings
Form D private placements▶$1.9MraisedApr 2025 · 23 investors · Other Health CareRule 506(b)
▶$1.9MraisedApr 2025 · 23 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Chuck PapageorgiouExecutive Officer, Director
- Mitch LarimoreDirector
- Jonathan GordonDirector
- Offering amount
- $6.5M
- Amount sold
- $1.9M
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$360KraisedJun 2024 · 12 investors · Other Health CareRule 506(b)
▶$360KraisedJun 2024 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Chuck PapageorgiouExecutive Officer, Director
- Mitch LarimoreDirector
- Jonathan GordonDirector
- Offering amount
- $500K
- Amount sold
- $360K
- First sale
- May 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $2.1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $255.4K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.